New York, New York (PRWEB) October 21, 2013
The nationwide law firm of Bernstein Liebhard LLP (http://www.consumerinjurylawyers.com) is investigating Risperdal lawsuits on behalf of young men and boys who developed a condition called gynecomastia, or male breast growth, allegedly due to their use of Risperdal. According to court documents, hundreds of product liability lawsuits are now moving forward in a consolidated proceeding underway in Philadelphia Common Pleas Court in Pennsylvania, all of which allege an association between Risperdal and male breast growth. (In Re: Risperdal Litigation, No. 00296)
“Risperdal lawsuits pending in the Pennsylvania proceeding accuse Johnson & Johnson of concealing the alleged link between Risperdal and male breast growth. We are interested in hearing from anyone who developed this condition while using Risperdal,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Risperdal lawsuit consultations to any individual who may have developed gynecomastia due to Risperdal.
Risperdal and Male Breast Growth
According to its prescribing information, Risperdal is an atypical antipsychotic drug used to treat adult and adolescent schizophrenia, as well as bipolar disorder in adults and children ages 10-to-17. Risperdal is also approved to treat irritability in children (5-to-16 years of age) with autistic disorder.* Research also indicates that off- label use of Risperdal to treat ADHD is also on the rise.**
According to research published in 2006 in the Journal of Clinical Psychopharmacology, Risperdal may cause the body to produce excessive amounts of a hormone called prolactin, which is known to stimulate breast growth and milk production in women. Excessive levels of prolactin were associated with gynecomastia in boys and the development of lactation in girls, according to the study authors. ***
According to the Mayo Clinic, gynecomastia is the swelling of the breast tissue in boys or men. Symptoms of Gynecomastia may include:
In the most severe cases, liposuction or mastectomy may be required to treat gynecomastia.****
In October 2012, Bloomberg.com reported that Johnson & Johnson had agreed to settle five
Risperdal lawsuits involving gynecomastia allegations. The cases were to be the first tried in the Risperdal litigation underway in Philadelphia. Those settlements came just months after the company agreed to pay more than $2 million to settle charges brought by the U.S. Department of Justice that it marketed Risperdal for unapproved uses. The company has also reached similar settlements with prosecutors in a number of states, Bloomberg.com said.****
Individuals who were treated with Risperdal are urged to contact Bernstein Liebhard LLP for a free legal consultation if they developed gynecomastia or male breast growth while taking this drug. To learn more about filing a Risperdal lawsuit, please contact the Firm by calling 800-511-5092.
*accessdata.fda.gov/drugsatfda_docs/label/2009/020272s056,020588s044,021346s033,021444s03lbl.pdf, Risperdal Prescribing Information, FDA, 2009
**health.usnews.com/health-news/news/articles/2012/08/07/more-kids-taking-antipsychotics-for-adhd-study, U.S. News & World Report, August 7, 2012
***journals.lww.com/psychopharmacology/Abstract/2006/04000/Risperidone_induced_Symptomatic.10.aspx, Journal of Clinical Psychopharmacology, April 2006
****Bloomberg.com/news/2012-10-04/johnson-johnson-agrees-to-settle-five-rispersal-suits.html, Bloomberg.com, October 10, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
Read the full story at http://www.prweb.com/releases/risperdal-lawsuit/risperdal-male-breast/prweb11252916.htm.
Copyright©2012 Vocus, Inc.
All rights reserved